Pain
Pain indications represent an emerging frontier in new drug development, with non-addictive analgesics targeting novel mechanisms serving as a key research focus.
INTRODUCTION
Boji Pharmaceuticals has accumulated extensive experience in pain management research, focusing on developing and evaluating effective treatment solutions for a wide range of pain conditions, from common to complex.
We are committed not only to exploring innovative therapies for moderate to severe pain—particularly cases requiring opioid intervention—but also to managing chronic pain, postoperative pain, and pain arising from specific conditions such as frozen shoulder or diabetic peripheral neuropathy.
Through a series of rigorous clinical trials, we are seeking safer and more effective treatment approaches, including but not limited to research on non-opioid analgesics and the development of biotechnology-based pain relief solutions. Our goal is to provide patients worldwide with superior pain relief experiences and enhance their quality of life.
Clinical Research Project Experience
- Moderate to severe pain requiring opioid medication
- Chronic pain
- Postoperative pain
- Relieve shoulder pain
- Diabetic Peripheral Neuropathy
PROJECT EXPERIENCE
Assisting in the successful approval of extended protection period for Toothache Stop Drops
Boji Pharmaceutical conducted a randomized, double-blind, double-dummy, positive-control parallel-group, multicenter clinical trial for this extended protection variety, evaluating Yatangting Drops in treating toothache caused by periodontitis and pericoronitis of wisdom teeth (wind-heat toothache syndrome). Conducted simultaneously across 18 centers in Guangdong, Sichuan, Tianjin, Hunan, Yunnan, Heilongjiang, and other provinces, the trial completed recruitment, enrollment, and follow-up for 480 subjects in less than six months, demonstrating Boji Pharmaceutical's exceptional capabilities in clinical research for new traditional Chinese medicines.